1 completed, 1 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Vrs-317: new trials by email Literature Review of Vrs-317 trials Research Report on Vrs-317
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-Acting Growth Hormone in Children Compared to Daily rhGH Somavaratan, rhGH - Growth Disorders | Phase 3 | Completed | Versartis Inc. | 138 | 2015-08-26 | 2022-12-30 |
| Versartis Long-Term Safety Study of Somavaratan somavaratan - Pediatric Growth Hormone Deficiency | Phase 2 / Phase 3 | Terminated | Versartis Inc. | 385 | 2014-03-03 | 2018-03-09 |
Dwarfism, Pituitary (2) · Growth Disorders (2) · Dwarfism (1) · Failure to Thrive (1)
Versartis Inc. (2)